title: Candida parapsilopsis fungemias in bone marrow transplant recipients: implications for azole prophylactic therapy.
authors.forename: J
authors.initials: J
authors.lastname: López-Jiménez
authors.forename: R
authors.initials: R
authors.lastname: Duarte-Palomino
authors.forename: E
authors.initials: E
authors.lastname: Cabezudo
authors.forename: J J
authors.initials: JJ
authors.lastname: Velasco-Martínez
authors.forename: A
authors.initials: A
authors.lastname: Sousa
authors.forename: J
authors.initials: J
authors.lastname: Odriozola
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000494:pharmacology / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D002175:Candida / Q000187:drug effects / Q000302:isolation & purification; D002177:Candidiasis / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control; D005260:Female; D015725:Fluconazole / Q000494:pharmacology / Q000627:therapeutic use*; D016469:Fungemia / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015994:Incidence; D017964:Itraconazole / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011183:Postoperative Complications
chemical_list: D000935:Antifungal Agents; D017964:Itraconazole; D015725:Fluconazole